Top Markets
Coin of the day
Photocure ASA Photocure ASA

Photocure ASA

PHO
株式のランク #19790
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
株価
$5.66
最終同期: 2026-08-25
時価総額
$150.59M
変化(1日)
0.00%
変化(1年)
-7.22%
NO
取引 Photocure ASA (PHO)

カテゴリー

Photocure ASA(PHO)の配当利回りの履歴
Photocure ASA(銘柄コード: PHO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Photocure ASA(PHO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)